BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 19462243)

  • 1. Cognitive neuropsychology of HIV-associated neurocognitive disorders.
    Woods SP; Moore DJ; Weber E; Grant I
    Neuropsychol Rev; 2009 Jun; 19(2):152-68. PubMed ID: 19462243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological assessment of HIV-infected populations in international settings.
    Robertson K; Liner J; Heaton R
    Neuropsychol Rev; 2009 Jun; 19(2):232-49. PubMed ID: 19455425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive disorders seen in HIV disease.
    Ungvarski PJ; Trzcianowska H
    Issues Ment Health Nurs; 2000; 21(1):51-70. PubMed ID: 10839052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.
    Cysique LA; Brew BJ
    Neuropsychol Rev; 2009 Jun; 19(2):169-85. PubMed ID: 19424802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and the central nervous system: a primer.
    Ellis RJ; Calero P; Stockin MD
    Neuropsychol Rev; 2009 Jun; 19(2):144-51. PubMed ID: 19415500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of HIV-associated neuropsychological impairment.
    Gorman AA; Foley JM; Ettenhofer ML; Hinkin CH; van Gorp WG
    Neuropsychol Rev; 2009 Jun; 19(2):186-203. PubMed ID: 19472057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropsychology of HIV/AIDS in older adults.
    Hardy DJ; Vance DE
    Neuropsychol Rev; 2009 Jun; 19(2):263-72. PubMed ID: 19247836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race-norming of neuropsychological tests.
    Gasquoine PG
    Neuropsychol Rev; 2009 Jun; 19(2):250-62. PubMed ID: 19294515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning.
    Cattie JE; Doyle K; Weber E; Grant I; Woods SP;
    J Clin Exp Neuropsychol; 2012; 34(9):906-18. PubMed ID: 22731608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia.
    Holguin A; Banda M; Willen EJ; Malama C; Chiyenu KO; Mudenda VC; Wood C
    AIDS Behav; 2011 Nov; 15(8):1895-901. PubMed ID: 21744118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special section of Neuropsychology Review on HIV/NeuroAIDS.
    Sullivan EV
    Neuropsychol Rev; 2009 Jun; 19(2):143. PubMed ID: 19466594
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging issues in the neuropsychology of HIV infection.
    Foley J; Ettenhofer M; Wright M; Hinkin CH
    Curr HIV/AIDS Rep; 2008 Nov; 5(4):204-11. PubMed ID: 18838060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.
    Martin-Thormeyer EM; Paul RH
    Neuropsychol Rev; 2009 Jun; 19(2):215-31. PubMed ID: 19468837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated research nosology for HIV-associated neurocognitive disorders.
    Antinori A; Arendt G; Becker JT; Brew BJ; Byrd DA; Cherner M; Clifford DB; Cinque P; Epstein LG; Goodkin K; Gisslen M; Grant I; Heaton RK; Joseph J; Marder K; Marra CM; McArthur JC; Nunn M; Price RW; Pulliam L; Robertson KR; Sacktor N; Valcour V; Wojna VE
    Neurology; 2007 Oct; 69(18):1789-99. PubMed ID: 17914061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use.
    Kamminga J; Lal L; Wright EJ; Bloch M; Brew BJ; Cysique LA
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):83-92. PubMed ID: 28284004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)].
    Clemente-Millana L; Portellano JA
    Rev Neurol; 2000 Dec 16-31; 31(12):1192-201. PubMed ID: 11205557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon.
    Kanmogne GD; Kuate CT; Cysique LA; Fonsah JY; Eta S; Doh R; Njamnshi DM; Nchindap E; Franklin DR; Ellis RJ; McCutchan JA; Binam F; Mbanya D; Heaton RK; Njamnshi AK
    BMC Neurol; 2010 Jul; 10():60. PubMed ID: 20626870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.